Skip to main content
Top
Published in: AIDS and Behavior 4/2010

01-08-2010 | Original Paper

Hazardous Drinking and HIV Sexual Risk Behaviors Among Injection Drug Users in Developing and Transitional Countries

Authors: Kamyar Arasteh, Don C. Des Jarlais, On Behalf of the WHO Phase II Drug Injection Collaborative Study Group

Published in: AIDS and Behavior | Issue 4/2010

Login to get access

Abstract

Studies in North America and Western Europe have reported an association between hazardous drinking and HIV sexual risk behaviors among injection drug users (IDUs). However, we lack such studies from developing and transitional countries, where different cultural norms and contexts of drinking may change this association. We used a multi-site study using standard survey instruments and methods to examine whether hazardous drinking is associated with HIV sexual risk behaviors (defined as unprotected sex and having multiple sex partners) among IDUs in 12 cities across different developing and transitional countries. Data were collected from May 1999 to November 2003. In individual site analyses, hazardous drinking was associated with increased HIV risk behaviors in 10 cities. Mixed effects models of the multi-site data, also, showed an association of hazardous drinking and HIV sexual risk behaviors. These findings in the context of the high prevalence of drinking in many sites point to the importance of addressing alcohol use in HIV education and prevention policy for IDUs.
Literature
go back to reference Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS (London, England), 18, 2295–2303. doi:10.1097/00002030-200411190-00010. Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS (London, England), 18, 2295–2303. doi:10.​1097/​00002030-200411190-00010.
go back to reference Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000). Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence, 58, 219–226. doi:10.1016/S0376-8716(99)00094-0.CrossRefPubMed Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000). Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence, 58, 219–226. doi:10.​1016/​S0376-8716(99)00094-0.CrossRefPubMed
go back to reference Centers for Disease Control and Prevention. (1982). Current trends update on acquired immune deficiency syndrome (AIDS)—United States. MMWR: Morbidity and Mortality Weekly Report, 31, 5078–5134. Centers for Disease Control and Prevention. (1982). Current trends update on acquired immune deficiency syndrome (AIDS)—United States. MMWR: Morbidity and Mortality Weekly Report, 31, 5078–5134.
go back to reference Centers for Disease Control and Prevention. (2003). HIV diagnoses among injection-drug users in states with HIV surveillance—25 states, 1994–2000. MMWR: Morbidity and Mortality Weekly Report, 52, 634–636. Centers for Disease Control and Prevention. (2003). HIV diagnoses among injection-drug users in states with HIV surveillance—25 states, 1994–2000. MMWR: Morbidity and Mortality Weekly Report, 52, 634–636.
go back to reference Centers for Disease Control and Prevention. (2004). HIV/AIDS surveillance report (Vol. 16). Atlanta: US Department of Health and Human Services. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. (2004). HIV/AIDS surveillance report (Vol. 16). Atlanta: US Department of Health and Human Services. Centers for Disease Control and Prevention.
go back to reference Dehne, K. L., Khodakevich, L., Hamers, F. F., & Schwartländer, B. (1999). The HIV/AIDS epidemic in eastern Europe: Recent patterns and trends and their implications for policy-making. AIDS (London, England), 13, 741–749. doi:10.1097/00002030-199905070-00002. Dehne, K. L., Khodakevich, L., Hamers, F. F., & Schwartländer, B. (1999). The HIV/AIDS epidemic in eastern Europe: Recent patterns and trends and their implications for policy-making. AIDS (London, England), 13, 741–749. doi:10.​1097/​00002030-199905070-00002.
go back to reference Deren, S., Kang, S. Y., Colon, H. M., Andia, J. F., & Robles, R. R. (2004). HIV incidence among high-risk Puerto Rican drug users: A comparison of East Harlem, New York, and Bayamon, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes, 36, 1067–1074. doi:10.1097/00126334-200408150-00010.CrossRefPubMed Deren, S., Kang, S. Y., Colon, H. M., Andia, J. F., & Robles, R. R. (2004). HIV incidence among high-risk Puerto Rican drug users: A comparison of East Harlem, New York, and Bayamon, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes, 36, 1067–1074. doi:10.​1097/​00126334-200408150-00010.CrossRefPubMed
go back to reference Des Jarlais, D. C., Perlis, T. E., Stimson, G. V., & Poznyak, V. (2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO drug injection study phase II. BMC Public Health, 6, 54. doi:10.1186/1471-2458-6-54.CrossRefPubMed Des Jarlais, D. C., Perlis, T. E., Stimson, G. V., & Poznyak, V. (2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO drug injection study phase II. BMC Public Health, 6, 54. doi:10.​1186/​1471-2458-6-54.CrossRefPubMed
go back to reference Fauci, A. S. (1986). Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. Proceedings of the National Academy of Sciences of the United States of America, 83, 9278–9283. doi:10.1073/pnas.83.24.9278.CrossRefPubMed Fauci, A. S. (1986). Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. Proceedings of the National Academy of Sciences of the United States of America, 83, 9278–9283. doi:10.​1073/​pnas.​83.​24.​9278.CrossRefPubMed
go back to reference Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.CrossRefPubMed Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.CrossRefPubMed
go back to reference Kissin, D. M., Zapata, L., Yorick, R., Vinogradova, E. N., Volkova, G. V., Cherkassova, E., et al. (2007). HIV seroprevalence in street youth, St Petersburg, Russia. AIDS (London, England), 21, 2333–2340. Kissin, D. M., Zapata, L., Yorick, R., Vinogradova, E. N., Volkova, G. V., Cherkassova, E., et al. (2007). HIV seroprevalence in street youth, St Petersburg, Russia. AIDS (London, England), 21, 2333–2340.
go back to reference National Institute on Alcohol Abuse and Alcoholism. (2004). Helping patients with alcohol problems: A health practitioner’s guide. Bethesda: National Institute on Alcohol Abuse and Alcoholism. National Institute on Alcohol Abuse and Alcoholism. (2004). Helping patients with alcohol problems: A health practitioner’s guide. Bethesda: National Institute on Alcohol Abuse and Alcoholism.
go back to reference Qian, H. Z., Schumacher, J. E., Chen, H. T., & Ruan, Y. H. (2006). Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduction Journal, 3, 4. doi:10.1186/1477-7517-3-4.CrossRefPubMed Qian, H. Z., Schumacher, J. E., Chen, H. T., & Ruan, Y. H. (2006). Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduction Journal, 3, 4. doi:10.​1186/​1477-7517-3-4.CrossRefPubMed
go back to reference Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., et al. (2001). Sex differences in risk factors for hiv seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine, 161, 1281–1288. doi:10.1001/archinte.161.10.1281.CrossRefPubMed Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., et al. (2001). Sex differences in risk factors for hiv seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine, 161, 1281–1288. doi:10.​1001/​archinte.​161.​10.​1281.CrossRefPubMed
go back to reference UNAIDS/WHO. (2005). AIDS epidemic update 2005. Geneva: UNAIDS/WHO. UNAIDS/WHO. (2005). AIDS epidemic update 2005. Geneva: UNAIDS/WHO.
go back to reference World Health Organization. (2004). Global status report on alcohol 2004. Geneva: World Health Organization. World Health Organization. (2004). Global status report on alcohol 2004. Geneva: World Health Organization.
go back to reference World Health Organization. (2005). Alcohol use and sexual risk behaviour: A cross-cultural study in eight countries. Geneva: World Health Organization. World Health Organization. (2005). Alcohol use and sexual risk behaviour: A cross-cultural study in eight countries. Geneva: World Health Organization.
Metadata
Title
Hazardous Drinking and HIV Sexual Risk Behaviors Among Injection Drug Users in Developing and Transitional Countries
Authors
Kamyar Arasteh
Don C. Des Jarlais
On Behalf of the WHO Phase II Drug Injection Collaborative Study Group
Publication date
01-08-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9491-0

Other articles of this Issue 4/2010

AIDS and Behavior 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine